BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 707504)

  • 21. Rectal absorption from aspirin suppositories in children and adults.
    Nowak MM; Brundhofer B; Gibaldi M
    Pediatrics; 1974 Jul; 54(1):23-6. PubMed ID: 4834297
    [No Abstract]   [Full Text] [Related]  

  • 22. Palatability of sucrose-, sorbitol-, and saccharin-sweetened activated charcoal formulations.
    Cooney DO
    Am J Hosp Pharm; 1980 Feb; 37(2):237-9. PubMed ID: 7361798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):586-9. PubMed ID: 5014316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of acute poisoning caused by carbamazepine, digoxin, and acetylsalicylic acid, with repeated doses of activated charcoal].
    Montoya-Cabrera MA; Escalante-Galindo P; Sauceda-García JM; Márquez-Enríquez LM; González-Cabello H; Flores-Alvarez E
    Gac Med Mex; 1995; 131(3):349-54. PubMed ID: 8582575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of "thickening" agents on the antidotal efficacy of activated charcoal.
    Gwilt PR; Perrier D
    Clin Toxicol; 1976; 9(1):89-92. PubMed ID: 1277772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE; Gillilan R; Watson WA
    J Toxicol Clin Toxicol; 1992; 30(4):549-56. PubMed ID: 1433426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of the form of preparation for the degree of adsorption of medical charcoal].
    Otto U; Stenberg B
    Lakartidningen; 1973 Aug; 70(31):2729-30. PubMed ID: 4786756
    [No Abstract]   [Full Text] [Related]  

  • 29. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL; Tierney MG; Dickinson GE
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large surface area activated charcoal and the inhibition of aspirin absorption.
    Dillon EC; Wilton JH; Barlow JC; Watson WA
    Ann Emerg Med; 1989 May; 18(5):547-52. PubMed ID: 2719366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of medicinal carbon granules and tablet on the adsorption of acetaminophen.
    Yamamoto K; Onishi H; Ito A; Machida Y
    Int J Pharm; 2007 Jan; 328(2):105-11. PubMed ID: 16942843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Easily swallowed formulations of antidote charcoals.
    Manes M; Mann JP
    Clin Toxicol; 1974; 7(4):355-64. PubMed ID: 4426177
    [No Abstract]   [Full Text] [Related]  

  • 33. Adsorption effects of activated charcoal on metaldehyde toxicity in rats.
    Shintani S; Goto K; Endo Y; Iwamoto C; Ohata K
    Vet Hum Toxicol; 1999 Feb; 41(1):15-8. PubMed ID: 9949477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C; Yagi H; Sakamoto M; Koyama Y; Ohmura T; Ohtani H; Sawada Y
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Superactive" charcoal adsorbs drugs as fast as standard antidotal charcoal.
    Cooney DO; Kane RP
    Clin Toxicol; 1980 Mar; 16(1):123-5. PubMed ID: 7389278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments.
    Chin L; Picchioni AL; Gillespie T
    Clin Toxicol; 1981 Jul; 18(7):865-71. PubMed ID: 7332642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does emergency medical services transport for pediatric ingestion decrease time to activated charcoal?
    Tuuri RE; Ryan LM; He J; McCarter RJ; Wright JL
    Prehosp Emerg Care; 2009; 13(3):295-303. PubMed ID: 19499464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated oral administration of activated charcoal for treating aspirin overdose in young children.
    Vertrees JE; McWilliams BC; Kelly HW
    Pediatrics; 1990 Apr; 85(4):594-8. PubMed ID: 2314974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.